The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global In-vitro Diagnostics Market Research Report 2024

Global In-vitro Diagnostics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1410768

No of Pages : 80

Ask Your Query

Synopsis

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

The global In-vitro Diagnostics market was valued at US$ 64460 million in 2023 and is anticipated to reach US$ 99070 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.

The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 29% of the whole market.

This report aims to provide a comprehensive presentation of the global market for In-vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-vitro Diagnostics.

Report Scope

The In-vitro Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the In-vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company (Partial List):

  • Biomerieux
  • Danaher
  • Roche Diagnostics
  • Becton, Dickinson
  • Bio-Rad Laboratories
  • Abbott
  • QIAGEN
  • Arkray
  • Sysmex
  • Ortho Clinical Diagnostics
  • Siemens
  • Thermo Fisher Scientific

Segment by Type

  • Instruments
  • Reagents
  • Data Management Systems

Segment by Application

  • Laboratories
  • Hospitals
  • Academia
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-vitro Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Reagents
1.2.4 Data Management Systems
1.3 Market by Application
1.3.1 Global In-vitro Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Academia
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Diagnostics Market Perspective (2019-2030)
2.2 In-vitro Diagnostics Growth Trends by Region
2.2.1 Global In-vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In-vitro Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 In-vitro Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 In-vitro Diagnostics Market Dynamics
2.3.1 In-vitro Diagnostics Industry Trends
2.3.2 In-vitro Diagnostics Market Drivers
2.3.3 In-vitro Diagnostics Market Challenges
2.3.4 In-vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-vitro Diagnostics Players by Revenue
3.1.1 Global Top In-vitro Diagnostics Players by Revenue (2019-2024)
3.1.2 Global In-vitro Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global In-vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-vitro Diagnostics Revenue
3.4 Global In-vitro Diagnostics Market Concentration Ratio
3.4.1 Global In-vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostics Revenue in 2023
3.5 In-vitro Diagnostics Key Players Head office and Area Served
3.6 Key Players In-vitro Diagnostics Product Solution and Service
3.7 Date of Enter into In-vitro Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Diagnostics Breakdown Data by Type
4.1 Global In-vitro Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global In-vitro Diagnostics Forecasted Market Size by Type (2025-2030)
5 In-vitro Diagnostics Breakdown Data by Application
5.1 Global In-vitro Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global In-vitro Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In-vitro Diagnostics Market Size (2019-2030)
6.2 North America In-vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In-vitro Diagnostics Market Size by Country (2019-2024)
6.4 North America In-vitro Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-vitro Diagnostics Market Size (2019-2030)
7.2 Europe In-vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In-vitro Diagnostics Market Size by Country (2019-2024)
7.4 Europe In-vitro Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-vitro Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific In-vitro Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In-vitro Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific In-vitro Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-vitro Diagnostics Market Size (2019-2030)
9.2 Latin America In-vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In-vitro Diagnostics Market Size by Country (2019-2024)
9.4 Latin America In-vitro Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-vitro Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa In-vitro Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In-vitro Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa In-vitro Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biomerieux
11.1.1 Biomerieux Company Detail
11.1.2 Biomerieux Business Overview
11.1.3 Biomerieux In-vitro Diagnostics Introduction
11.1.4 Biomerieux Revenue in In-vitro Diagnostics Business (2019-2024)
11.1.5 Biomerieux Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher In-vitro Diagnostics Introduction
11.2.4 Danaher Revenue in In-vitro Diagnostics Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics In-vitro Diagnostics Introduction
11.3.4 Roche Diagnostics Revenue in In-vitro Diagnostics Business (2019-2024)
11.3.5 Roche Diagnostics Recent Development
11.4 Becton, Dickinson
11.4.1 Becton, Dickinson Company Detail
11.4.2 Becton, Dickinson Business Overview
11.4.3 Becton, Dickinson In-vitro Diagnostics Introduction
11.4.4 Becton, Dickinson Revenue in In-vitro Diagnostics Business (2019-2024)
11.4.5 Becton, Dickinson Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories In-vitro Diagnostics Introduction
11.5.4 Bio-Rad Laboratories Revenue in In-vitro Diagnostics Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott In-vitro Diagnostics Introduction
11.6.4 Abbott Revenue in In-vitro Diagnostics Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN In-vitro Diagnostics Introduction
11.7.4 QIAGEN Revenue in In-vitro Diagnostics Business (2019-2024)
11.7.5 QIAGEN Recent Development
11.8 Arkray
11.8.1 Arkray Company Detail
11.8.2 Arkray Business Overview
11.8.3 Arkray In-vitro Diagnostics Introduction
11.8.4 Arkray Revenue in In-vitro Diagnostics Business (2019-2024)
11.8.5 Arkray Recent Development
11.9 Sysmex
11.9.1 Sysmex Company Detail
11.9.2 Sysmex Business Overview
11.9.3 Sysmex In-vitro Diagnostics Introduction
11.9.4 Sysmex Revenue in In-vitro Diagnostics Business (2019-2024)
11.9.5 Sysmex Recent Development
11.10 Ortho Clinical Diagnostics
11.10.1 Ortho Clinical Diagnostics Company Detail
11.10.2 Ortho Clinical Diagnostics Business Overview
11.10.3 Ortho Clinical Diagnostics In-vitro Diagnostics Introduction
11.10.4 Ortho Clinical Diagnostics Revenue in In-vitro Diagnostics Business (2019-2024)
11.10.5 Ortho Clinical Diagnostics Recent Development
11.11 Siemens
11.11.1 Siemens Company Detail
11.11.2 Siemens Business Overview
11.11.3 Siemens In-vitro Diagnostics Introduction
11.11.4 Siemens Revenue in In-vitro Diagnostics Business (2019-2024)
11.11.5 Siemens Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific In-vitro Diagnostics Introduction
11.12.4 Thermo Fisher Scientific Revenue in In-vitro Diagnostics Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock